Haibin Xia

4.7k total citations · 2 hit papers
80 papers, 3.5k citations indexed

About

Haibin Xia is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Haibin Xia has authored 80 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 30 papers in Genetics and 15 papers in Oncology. Recurrent topics in Haibin Xia's work include Virus-based gene therapy research (27 papers), RNA Interference and Gene Delivery (16 papers) and CRISPR and Genetic Engineering (14 papers). Haibin Xia is often cited by papers focused on Virus-based gene therapy research (27 papers), RNA Interference and Gene Delivery (16 papers) and CRISPR and Genetic Engineering (14 papers). Haibin Xia collaborates with scholars based in China, United States and Australia. Haibin Xia's co-authors include Qinwen Mao, Beverly L. Davidson, Henry L. Paulson, Dan Xiao, Weifeng Zhang, Steven Eliason, Inês Martins, Harry T. Orr, Linda Yang and Robert M. Kotin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Biotechnology.

In The Last Decade

Haibin Xia

79 papers receiving 3.4k citations

Hit Papers

Role of ... 2002 2026 2010 2018 2023 2002 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haibin Xia China 19 2.4k 823 457 417 316 80 3.5k
Qinwen Mao United States 24 2.5k 1.1× 811 1.0× 719 1.6× 727 1.7× 273 0.9× 102 4.0k
Tilo Kunath United Kingdom 32 3.9k 1.7× 662 0.8× 693 1.5× 447 1.1× 265 0.8× 76 5.6k
Barkur S. Shastry United States 23 2.2k 0.9× 594 0.7× 274 0.6× 234 0.6× 230 0.7× 78 3.4k
Philippe Chafey France 28 2.4k 1.0× 766 0.9× 540 1.2× 344 0.8× 197 0.6× 60 3.8k
Feng Wu China 34 1.4k 0.6× 353 0.4× 231 0.5× 367 0.9× 584 1.8× 67 3.0k
Seigo Tanaka Japan 23 3.3k 1.4× 717 0.9× 412 0.9× 633 1.5× 135 0.4× 45 4.2k
Hitoshi Osaka Japan 37 3.0k 1.3× 1.3k 1.6× 980 2.1× 510 1.2× 167 0.5× 235 5.0k
Deborah A. Swing United States 28 2.0k 0.8× 665 0.8× 338 0.7× 261 0.6× 185 0.6× 39 3.2k
Hsiao‐Huei Chen Canada 31 1.9k 0.8× 981 1.2× 364 0.8× 221 0.5× 240 0.8× 73 3.2k
Marianna Sikorska Canada 39 2.9k 1.2× 295 0.4× 504 1.1× 330 0.8× 380 1.2× 78 4.3k

Countries citing papers authored by Haibin Xia

Since Specialization
Citations

This map shows the geographic impact of Haibin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibin Xia more than expected).

Fields of papers citing papers by Haibin Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibin Xia. The network helps show where Haibin Xia may publish in the future.

Co-authorship network of co-authors of Haibin Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Haibin Xia. A scholar is included among the top collaborators of Haibin Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibin Xia. Haibin Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Lingling, et al.. (2025). Novel oncolytic adenovirus-based PEPvIII vaccine displays a super antitumor effect in glioma models. Journal for ImmunoTherapy of Cancer. 13(9). e010750–e010750. 1 indexed citations
2.
Zhao, Junli, Xiao-Hong Sun, Peiyan Yang, et al.. (2023). Expression and functional analysis of fam76b in zebrafish. Fish & Shellfish Immunology. 142. 109161–109161. 4 indexed citations
4.
Zhang, Weifeng, Dan Xiao, Qinwen Mao, & Haibin Xia. (2023). Role of neuroinflammation in neurodegeneration development. Signal Transduction and Targeted Therapy. 8(1). 267–267. 749 indexed citations breakdown →
5.
Zhang, Jie, et al.. (2022). E3 ubiquitin ligase Trim33 ubiquitylates Annexin A2 to promote NF-κB induced skin inflammation in psoriasis. Journal of Dermatological Science. 107(3). 160–168. 16 indexed citations
6.
Jiang, Wei, Haibin Xia, Fei Hu, et al.. (2020). FMRP-absence-induced up-regulation of hypothalamic MAP1B expression decreases AgRP level linking with reduces in food intake and body weight. Neurochemistry International. 140. 104847–104847. 9 indexed citations
8.
Shan, Linlin, et al.. (2018). Establishment of a DGKθ Endogenous Promoter Luciferase Reporter HepG2 Cell Line for Studying the Transcriptional Regulation of DGKθ Gene. Applied Biochemistry and Biotechnology. 187(4). 1344–1355. 4 indexed citations
9.
Li, Yanqing, et al.. (2016). Production and Characterization of Monoclonal Antibodies against Human Nuclear Protein FAM76B. PLoS ONE. 11(3). e0152237–e0152237. 3 indexed citations
10.
Wang, Dongyang, Yuanxu Guo, Yanqing Li, et al.. (2015). Detection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibody. Oncology Letters. 9(6). 2603–2608. 22 indexed citations
11.
Li, Xing, Qinwen Mao, Dongyang Wang, & Haibin Xia. (2012). A novel Ad5/11 chimeric oncolytic adenovirus for improved glioma therapy. International Journal of Oncology. 41(6). 2159–2165. 10 indexed citations
12.
Wang, Yueying, et al.. (2012). Establishment of a cell line carrying single copy of an exogenous mutant reporter gene for assaying the biological activity of ZFNs. Journal of Biotechnology. 162(2-3). 191–196. 1 indexed citations
13.
Mao, Qinwen, et al.. (2011). Domain-Specific Monoclonal Antibodies Produced Against Human PGRN. Hybridoma. 30(3). 271–278. 9 indexed citations
14.
Wang, Dongyang, Shihai Liu, Qinwen Mao, Junli Zhao, & Haibin Xia. (2011). A novel vector for a rapid generation of fiber-mutant adenovirus based on one step ligation and quick screening of positive clones. Journal of Biotechnology. 152(3). 72–76. 3 indexed citations
15.
Mao, Qinwen, et al.. (2011). A rapid generation of adenovirus vector with a genetic modification in hexon protein. Journal of Biotechnology. 157(3). 373–378. 8 indexed citations
16.
Li, Xing, Shihai Liu, Dongyang Wang, Hao Chen, & Haibin Xia. (2011). Adenoviral delivered eGFP-intron splicing system for multiple gene RNAi. Biotechnology Letters. 33(9). 1723–1728. 7 indexed citations
17.
Mao, Qinwen, Haibin Xia, & Beverly L. Davidson. (2003). Intracellular trafficking of CLN3, the protein underlying the childhood neurodegenerative disease, Batten disease. FEBS Letters. 555(2). 351–357. 26 indexed citations
18.
Xia, Haibin, Qinwen Mao, Henry L. Paulson, & Beverly L. Davidson. (2002). siRNA-mediated gene silencing in vitro and in vivo. Nature Biotechnology. 20(10). 1006–1010. 696 indexed citations breakdown →
19.
Wang, Ge, Greg Williams, Haibin Xia, et al.. (2002). Apical barriers to airway epithelial cell gene transfer with amphotropic retroviral vectors. Gene Therapy. 9(14). 922–931. 21 indexed citations
20.
Metharom, Pat, et al.. (2001). Development of disabled, replication-defective gene transfer vectors from the Jembrana disease virus, a new infectious agent of cattle. Veterinary Microbiology. 80(1). 9–22. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026